Joan Valls

Joan Valls

Auto-generated profile, based on publicly available information

Joan Valls

Systems Biology and Statistical Methods for Biomedical Research, IRBLleida, University of Lleida, Rovira Roure 80, 25198 Lleida, Spain

Research Focus & Metrics

Academic Career Length

22Years (2005-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
23 May 2006 in Bioinformatics
Verified
Journal Article
Open access
PDF file
XSXavier Solé
Xavier Solé
EGElisabet Guinó
Elisabet Guinó
JVJoan Valls
Joan Valls
RIRaquel Iniesta
Raquel Iniesta
VMVictor Moreno
Victor Moreno
Summary: A web-based application has been designed from a genetic epidemiology point of view to analyze association studies. Main capabilities include descriptive analysis, test for Hardy–Weinberg equilibrium and linkage disequilibrium. Analysis of association is based on linear or logistic regression according to the response variable (quantitative or binary disease status, respectively). Analysis of single SNPs: multiple inheritance models (co-dominant, dominant, recessive, over-dominant and log-additive), and analysis of interactions (gene–gene or gene–environment). Analysis of multiple SNPs: haplotype frequency estimation, analysis of association of haplotypes with the response, including analysis of interactions. Availability: . Source code for local installation is available under GNU license. Contact:v.moreno@iconcologia.net Supplementary Information: Figures with a sample run are available on Bioinformatics online. A detailed online tutorial is available within the application.

1 April 2007 in Journal of Clinical Oncology
Verified
Journal Article
Open access
ISItziar Salaverria
Itziar Salaverria
AZAndreas Zettl
Andreas Zettl
SBSílvia Beà
Sílvia Beà
VMVictor Moreno
Victor Moreno
JVJoan Valls
Joan Valls
ECElias Campo
Elias Campo
Purpose: To compare the genetic relationship between cyclin D1–positive and cyclin D1–negative mantle cell lymphomas (MCLs) and to determine whether specific genetic alterations may add prognostic information to survival prediction based on the proliferation signature of MCLs. Patients and Methods: Seventy-one cyclin D1–positive and six cyclin D1–negative MCLs previously characterized by gene expression profiling were examined by comparative genomic hybridization (CGH). Results: Cyclin D1–negative MCLs were genetically characterized by gains of 3q, 8q, and 15q, and losses of 1p, 8p23-pter, 9p21-pter, 11q21-q23, and 13q that were also the most common alterations in conventional MCLs. Parallel analysis of CGH aberrations and locus-specific gene expression profiles in cyclin D1–positive patients showed that chromosomal imbalances had a substantial impact on the expression levels of the genes located in the altered regions. The analysis of prognostic factors revealed that the proliferation signature, the number of chromosomal aberrations, gains of 3q, and losses of 8p, 9p, and 9q predicted survival of MCL patients. A multivariate analysis showed that the gene expression-based proliferation signature was the strongest predictor for shorter survival. However, 3q gains and 9q losses provided prognostic information that was independent of the proliferative activity. Conclusion: Cyclin D1–positive and –negative MCLs share the same secondary genetic aberrations, supporting the concept that they correspond to the same genetic entity. The integration of genetic information on chromosome 3q and 9q alterations into a proliferation signature-based model may improve the ability to predict survival in patients with MCL.

19 March 2012 in Oncogene
Verified
Journal Article
Closed access
VSV Stresing
V Stresing
EBE Baltziskueta
E Baltziskueta
NRN Rubio
N Rubio
JBJ Blanco
J Blanco
MAMaC Arriba
MaC Arriba
ASAngels Sierra
Angels Sierra

20 October 2008 in Journal of Clinical Oncology
Verified
Journal Article
Closed access
PDF file
EHElena Hartmann
Elena Hartmann
VFVerònica Fernàndez
Verònica Fernàndez
VMVictor Moreno
Victor Moreno
JVJoan Valls
Joan Valls
Luis HernándezLuis Hernández
Luis Hernández
ECElías Campo
Elías Campo
Purpose Despite the common underlying translocation t(11;14) involving cyclin D1 that is present in nearly all cases of mantle-cell lymphoma (MCL), the clinical course of the disease is highly variable. The aim of the present study was to develop a quantitative gene expression–based model to predict survival in newly diagnosed patients with MCL that involves a minimum number of genes and is applicable to fresh-frozen and formalin-fixed, paraffin-embedded (FFPE) tumor samples. Patients and Methods The expression of 33 genes with potential prognostic and pathogenetic impact in MCL was analyzed using quantitative reverse-transcription polymerase chain reactions (qRT-PCR) in a low-density array format in frozen tumor samples from 73 patients with MCL. Multivariate Cox methods and stepwise algorithms were applied to build gene expression-based survival predictors. An optimized five-gene model was subsequently applied to FFPE tumor samples from 13 patients with MCL from the initial series and to 42 independent MCL samples. Results The optimized survival predictor was composed of the five genes RAN, MYC, TNFRSF10B, POLE2, and SLC29A2 and was validated for application in FFPE tissue samples. It allowed the survival prediction of patients with MCL with widely disparate clinical outcome and was superior to the immunohistochemical marker Ki-67, an established prognostic factor in MCL. Conclusion We here present a validated qRT-PCR–based test for survival prediction in patients with MCL that is applicable to fresh frozen as well as to FFPE tissue specimens. This test may prove useful to guide individualized treatment approaches for patients with MCL.

1 July 2006 in Nucleic Acids Research
Verified
Journal Article
Open access
DMD. Montaner
D. Montaner
JTJ. Tarraga
J. Tarraga
JHJ. Huerta-Cepas
J. Huerta-Cepas
JBJ. Burguet
J. Burguet
JVJ. M. Vaquerizas
J. M. Vaquerizas
JDJoaquin Dopazo
Joaquin Dopazo
The Gene Expression Profile Analysis Suite (GEPAS) has been running for more than four years. During this time it has evolved to keep pace with the new interests and trends in the still changing world of microarray data analysis. GEPAS has been designed to provide an intuitive although powerful web-based interface that offers diverse analysis options from the early step of preprocessing (normalization of Affymetrix and two-colour microarray experiments and other preprocessing options), to the final step of the functional annotation of the experiment (using Gene Ontology, pathways, PubMed abstracts etc.), and include different possibilities for clustering, gene selection, class prediction and array-comparative genomic hybridization management. GEPAS is extensively used by researchers of many countries and its records indicate an average usage rate of 400 experiments per day. The web-based pipeline for microarray gene expression data, GEPAS, is available at http://www.gepas.org.

1 January 2015 in Journal of Diabetes Research
Verified
Journal Article
Open access
PDF file
NANuria Alcubierre
Nuria Alcubierre
JVJoan Valls
Joan Valls
EREsther Rubinat
Esther Rubinat
GCGonzalo Cao
Gonzalo Cao
AEAureli Esquerda
Aureli Esquerda
Didac MauricioDidac Mauricio
Didac Mauricio
There is very few evidences on the role of vitamin D in the development of diabetic retinopathy. The aim of the current study was to explore whether there is an association of vitamin D status and diabetic retinopathy in type 2 diabetes. Two groups of patients were selected: 139 and 144 patients with and without retinopathy, respectively, as assessed by an experienced ophthalmologist. Subjects with advanced late diabetic complications were excluded to avoid confounding biases. 25-Hydroxy-vitamin D3(25(OH)D) concentrations and vitamin D deficiency were associated with the presence of diabetic retinopathy. Additionally, patients with more advanced stages of retinopathy (grades 2–4) had lower concentrations of 25(OH)D and were more frequently vitamin D deficient as compared with patients not carrying this eye complication. In conclusion, our study confirms the association of vitamin D deficiency with the presence and severity of diabetic retinopathy in type 2 diabetes. Further experimental and prospective studies on this issue are clearly warranted.